NCT06769308

Brief Summary

Sedation and analgesia are fundamental tools for managing critical patients who require mechanical ventilation. However, recent scientific literature highlights that excessive sedation in these patients can increase the duration of mechanical ventilation and extend the overall length of stay in intensive care, as well as expose them to a higher risk of hypotension, venous thrombosis, and nosocomial pneumonia. The titration of sedation and analgesia in intensive care, on the other hand, is currently based primarily on clinical parameters (such as the onset of delirium, asynchronies with the ventilator, for example), which can lead to treatments not proportionate to the patient's needs. The present study aims to evaluate the application, in an intensive care setting, of the Conox® system, a device already widely used in monitoring the anesthetic plan in the operating room. This tool would allow, through the processing of an EEG trace, the assessment of the level of sedation (qCON) and the probable algic response (qNOX), thus providing valuable information for the fine-tuning of the analgo-sedative plan.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
174

participants targeted

Target at P75+ for not_applicable

Timeline
15mo left

Started Jan 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Jan 2024Jul 2027

Study Start

First participant enrolled

January 1, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 23, 2024

Completed
6 months until next milestone

First Posted

Study publicly available on registry

January 10, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2027

Last Updated

January 10, 2025

Status Verified

July 1, 2024

Enrollment Period

3 years

First QC Date

July 23, 2024

Last Update Submit

January 9, 2025

Conditions

Keywords

ICU, sedation, analgesia, mechanical ventilation

Outcome Measures

Primary Outcomes (1)

  • Ventilator free days

    The number of days without ventilation

    Day 28

Secondary Outcomes (3)

  • Delirium occurrence

    Daily after extubation

  • ICU lenght of stay

    ICU discharge

  • Drug consumption

    ICU discharge

Study Arms (2)

Standard of care sedation

ACTIVE COMPARATOR

The patients will be sedated according to the current standard of care (Behavioral pain scale and Richmond Agitation-Sedation Scale).

Procedure: Sedation titration according to standard of care

EEG guided sedation

EXPERIMENTAL

The patients will be sedated according to the EEG derived indexes (qCON/qNOX).

Device: Sedation titration according to qEEG

Interventions

Sedation will be titrated according to the EEG derived indexes (qCON/qNOX)

EEG guided sedation

Sedation will be provided according to the standard of care of the unit (clinical scales)

Standard of care sedation

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-90 years Admission to the ICU for less than 24 hours Expected mechanical ventilation for \>48 hours Ongoing sedation

You may not qualify if:

  • Mechanical ventilation (MV) for less than 48 hours Patient or next of kin refusal to participate BMI \> 35 Cerebrovascular disease Scheduled surgery Neuromuscular disease Presence of craniofacial trauma that prevents the placement of electrodes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Azienda Ospedaliera Universitaria Sant'Anna

Ferrara, Italy, 44100, Italy

RECRUITING

Azienda Ospedaliera Universitaria Federico II - "Policlinico"

Napoli, Napoli, Italy

NOT YET RECRUITING

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Gaetano Scaramuzzo, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

July 23, 2024

First Posted

January 10, 2025

Study Start

January 1, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

July 31, 2027

Last Updated

January 10, 2025

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations